In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Clinical trial to evaluate the safety and efficacy of YK012 in primary membranous nephropathy- Globally, this is the first bispecific CD19-directed CD3 T cell engager immunotherapy for this autoimmune ...

To mark World Blood Cancer Day tomorrow, we’re remembering how we’ve been affected by the type of cancer and our efforts to ...

The company's flagship assay uses whole-genome sequencing to identify patients with high-risk multiple myeloma and determine which patients won't respond to therapies.

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

The following is a summary of “Epidemiology of patients treated for multiple myeloma using a new algorithm in the French ...